Engineered endocrine objects tolerate hypoxia in macroencapsulation devices and enable subcutaneous engraftment in diabetic mice
Islet encapsulation has been pursued for decades as a potential immunosuppression-free transplantation strategy to treat type 1 diabetes (T1D). The encapsulation device protects islets from immune cell-contact mediated killing, but it also prevents vascular penetration and intra-islet vascularization, leading to poor mass transfer and islet central necrosis. In healthy pancreas, islets with sizes > ~40 μm are vascularized while non-islet endocrine cell clusters below ~40 μm exist without internal capillaries. Here, we developed scalable and reproducible engineered endocrine objects (EEOs) as small as ~47 μm by mesh-induced fragmentation of native islets, followed by a recovery culture. Under hypoxic culture condition (1% O2 for 24 hours), EEOs showed enhanced viability of >90%, compared to 49% for the native islet control. With a flat, thin (0.5-mm-thick) alginate-based macroencapsulation device, rat EEOs at a marginal dose of 300 islet equivalents (IEQ) achieved glycemic control for over 5 weeks in the challenging, hypoxic subcutaneous space of immunocompetent diabetic mice. The engrafted mice displayed near-physiological glycemic profiles upon glucose challenge, and the retrieved EEOs showed enhanced viability with significantly reduced central necrosis compared with native islets. Overall, engineering hypoxia-resistance into cellular products mitigates intrinsic constraints of encapsulation devices, offering a promising strategy for convenient, immunosuppression-free subcutaneous islet transplantation.
Authors
- James Arthur Flanders (ORCID: https://orcid.org/0000-0002-9878-5736)
- Kecheng Wang (ORCID: https://orcid.org/0000-0002-6896-5189)
- Phuong Le Tran (ORCID: https://orcid.org/0000-0002-8082-0142)
- Kento Okada (ORCID: https://orcid.org/0000-0003-4658-6871)
- Minseok Lee (ORCID: https://orcid.org/0000-0002-9180-7699)
- Min Jin (ORCID: https://orcid.org/0000-0003-0073-4816)
- Jerry Deng
- Bo Wang
- Minglin Ma
Institutions
- Cornell University (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-12
- DOI
- https://doi.org/10.64898/2026.11.10.765512
- Primary Topic
- Pancreatic function and diabetes
- Type
- preprint
Funders
- National Institute of Diabetes and Digestive and Kidney Diseases